Theratechnologies (TSX: TH)
CA$1.85
(-2.1%)
-CA$0.04
Price as of April 24, 2024, 3:59 p.m. ET
Theratechnologies Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Theratechnologies Company Info
Theratechnologies, Inc. is a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which is an approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. The company was founded on October 19, 1993 and is headquartered in Montréal, Canada.
News & Analysis
Valuation
Earnings Transcripts
Target Hospitality Corp. (TH) Q2 2019 Earnings Call Transcript
TH earnings call for the period ending June 30, 2019.
Motley Fool Transcription | Aug 14, 2019
Target Hospitality Corp. (TH) Q1 2019 Earnings Call Transcript
TH earnings call for the period ending March 31, 2019.
Motley Fool Transcription | May 14, 2019
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.